In this issue:
Antidepressants reduce the risk of intubation or death in COVID-19
Youth depression increases long-term risk for a range of diseases and premature death
CYP2C19/CYP2D6 genotyping may allow personalised optimisation of psychiatric drug doses
Precision medicine gains traction in psychiatry with blood test for depression and bipolar
Cumulative impact of adverse prenatal exposures with child psychopathology
CBT efficacious for paediatric prolonged grief disorder
Paucity of high-quality guidance regarding healthcare for gender minority/trans people
Intravenous ketamine demonstrates short-term efficacy in adolescent depression
Post-marketing safety concerns with esketamine
Sequential use of pharmacotherapy and psychotherapy improves major depressive disorder
Please login below to download this issue (PDF)